CRK12-IN-2
CAS No. 1990479-17-8
CRK12-IN-2( —— )
Catalog No. M35735 CAS No. 1990479-17-8
CRK12-IN-2 is a potent inhibitor of CRK12.CRK12-IN-2 inhibits the parasite, with EC50 values of 3.2 and 0.08 nM for Trypanosoma congolense and Trypanosoma vivax, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | Get Quote |
|
| 5MG | 459 | Get Quote |
|
| 10MG | 657 | Get Quote |
|
| 25MG | 994 | Get Quote |
|
| 50MG | 1371 | Get Quote |
|
| 100MG | 1773 | Get Quote |
|
| 500MG | 3537 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCRK12-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCRK12-IN-2 is a potent inhibitor of CRK12.CRK12-IN-2 inhibits the parasite, with EC50 values of 3.2 and 0.08 nM for Trypanosoma congolense and Trypanosoma vivax, respectively.
-
DescriptionCRK12-IN-2 (compound 2) is an inhibitor of CRK12. CRK12-IN-2 shows potency against Trypanosoma congolense and Trypanosoma vivax with EC50 values of 3.2 and 0.08 nM. CRK12-IN-2 can be used for the research of animal trypanosomiasis.
-
In Vitro——
-
In VivoCRK12-IN-2 (10 mg/kg; s.c. once daily for 4 days) effectively cures mice with T. congolense- and T. vivax-infection.Animal Model:Mice with T. congolense and T. vivax infection Dosage:10 mg/kg Administration: Subcutaneous injection; 10 mg/kg once daily; for 4 days Result:Fully cured both T. congolense- and T. vivax-infected mice for 4 days at a dose of 10 mg/kg.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetParasite
-
RecptorParasite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1990479-17-8
-
Formula Weight529.67
-
Molecular FormulaC23H33F2N5O3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(C=1SC(N[C@@H]2CC[C@@H](NS(CC(C)C)(=O)=O)CC2)=NC1N)C3=C(F)C=C(CN(C)C)C=C3F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Smith A, et al. Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal Trypanosomiasis. J Med Chem. 2022 Apr 14;65(7):5606-5624.?
molnova catalog
related products
-
Avermectin B1a
Avermectin B1a is a macrocyclic lactone disaccharide anthelmintic agent .
-
5-(3-bromo-4,5-dihyd...
Antileishmanial agent-2 is a 3-Br-isoxazoline-Based Inhibitors against Plasmodium falciparum (D10 and W2 strains) and Leishmania spp. (L. infantum and L. tropica) Promastigotes with IC50s of 0.035, 0.058, 3.5 and 7.5 μM.
-
MMV688533
MMV688533 has antimalarial activity.
Cart
sales@molnova.com